Status:
COMPLETED
Misoprostol for Non-Viable Pregnancies
Lead Sponsor:
Madigan Army Medical Center
Conditions:
Abortifacient Agents, Nonsteroidal
Abortion, Incomplete
Eligibility:
FEMALE
18-40 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to examine the effectiveness of Misoprostol (Cytotec; GD Searle and Co., Chicago, IL) for the management of non-viable first trimester pregnancies. Specifically, Misoprost...
Detailed Description
Patients presenting to the OB/GYN clinic with a nonviable gestation, diagnosis documented by endovaginal ultrasound will be enrolled. Ultrasonic findings will be verified by two of the resident staff ...
Eligibility Criteria
Inclusion
- Pregnant patients with nonviable pregnancy document by ultrasound
- Gestation at or less than 13 weeks by ultrasound measurements
- Clinically stable as determined by provider
- Afebrile
- Hematocrit \> 30
- Over 18 years of age
Exclusion
- History of allergy to, or intolerance of, misoprostol
- Refusal to abstain from intercourse for 72 hours
- Significant vaginal bleeding (\> 2 pad/hr)
- History of inflammatory bowel disease
Key Trial Info
Start Date :
March 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00426491
Start Date
March 1 1999
End Date
October 1 2006
Last Update
February 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Madigan Army Medical Center
Tacoma, Washington, United States, 98431